WHO ICTRP trial
A real world study of fulvestrant(qingkeyi) in hormone receptor positive…
ChiCTR2100046365 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2100046365 |
|---|---|
| Public title | A real world study of fulvestrant(qingkeyi) in hormone receptor positive advanced breast cancer |
| Scientific title | A real world study of fulvestrant(qingkeyi) in hormone receptor positive advanced breast cancer |
| Primary sponsor | The First Affiliated Hospital of Guangxi Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Observational study |
| Phase | 4 |
| Countries | China |
| Conditions | breast cancer |
| Interventions | Test group:Fulvestrant |
| Registration date | May 14, 2021 |
| Target size | Test group:2000 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: